VAKIENER VICTORIA sold 21.9% of their position (10.04K shares) of ARROWHEAD PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $679.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/23/2025ACC: 0001826263-25-000006
Director
Since May 2022
-10.04K
Net shares
Net seller
$679.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
10.04K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−2.80K
Price / share
$66.63
Trade value
$186.50K
% of position
6.1%
12/19/2025
45.76K→42.96K
Common Stock
Direct
Shares
−5.28K
Price / share
$67.97
Trade value
$358.95K
% of position
12.3%
12/19/2025
42.96K→37.68K
Common Stock
Direct
Shares
−1.96K
Price / share
$68.39
Trade value
$134.04K
% of position
5.2%
12/19/2025
37.68K→35.72K
Total
Net shares
−10.04K
Net value
-$679.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | S · Sale | −2.80K | $66.63 | $186.50K | 6.1% | 45.76K | 42.96K |
| Common Stock Direct | 12/19/2025 | S · Sale | −5.28K | $67.97 | $358.95K | 12.3% | 42.96K | 37.68K |
| Common Stock Direct | 12/19/2025 | S · Sale | −1.96K | $68.39 | $134.04K | 5.2% | 37.68K | 35.72K |
| Total | −10.04K | -$679.49K | ||||||
Derivative Transactions0
No derivative transactions reported